
Current Price | $8.27 | Mkt Cap | $1.6B |
---|---|---|---|
Open | $8.00 | P/E Ratio | -6.83 |
Prev. Close | $8.27 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $7.93 - $8.30 | Volume | 2,986,800 |
52-Wk Range | $7.20 - $15.43 | Avg. Daily Vol. | 2,828,713 |
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
Current Price | $8.27 | Mkt Cap | $1.6B |
---|---|---|---|
Open | $8.00 | P/E Ratio | -6.83 |
Prev. Close | $8.27 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $7.93 - $8.30 | Volume | 2,986,800 |
52-Wk Range | $7.20 - $15.43 | Avg. Daily Vol. | 2,828,713 |
The best Bull and Bear pitches based on recency and number of recommendations.
Already profitable; growing; good pipeline
As I predicted, BioCryst still had a little life left which allowed me to escape my green thumb and flip turn into a red one. 33% jump today, and all because of this:BioCryst Pharmaceuticals, Inc. today announced that it received a preliminary… More
Read the most recent pitches from players about BCRX.
Recs
Already profitable; growing; good pipeline
Recs
COVID-19 biotech should continue to grow with oral delivery system of vaccine
Recs
Expecting positive sales of over $500 on Berotralstat approval. Plus early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases plus patient dosing underway in galidesivir trial in COVID-19 patients in Brazil. All sounds quite positive and worth a flyer.
Find the members with the highest scoring picks in BCRX.
Chemnerd (40.14) Score: +564.96
The Score Leader is the player with the highest score across all their picks in BCRX.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
cozynite | 35.23 | 3/14/2013 |
![]() |
5Y | $1.31 | +531.30% | +166.28% | +365.02 | 0 Comment | |
KeepYourCoolFool | 95.85 | 7/29/2009 |
![]() |
5Y | $10.58 | -21.83% | +329.80% | +351.64 | 0 Comment | |
DRASH5 | 23.99 | 7/29/2009 |
![]() |
3W | $10.28 | -19.55% | +331.13% | +350.68 | 0 Comment | |
BASSTRAX | 66.94 | 8/31/2009 |
![]() |
1Y | $12.99 | -36.34% | +311.16% | +347.50 | 0 Comment | |
WeathermanGR13 | 93.74 | 8/17/2009 |
![]() |
5Y | $9.88 | -16.30% | +324.22% | +340.52 | 0 Comment | |
SpencerHar | < 20 | 8/3/2009 |
![]() |
1Y | $9.10 | -9.12% | +319.85% | +328.97 | 0 Comment | |
BadB0y4Lyfe | 25.90 | 8/10/2009 |
![]() |
5Y | $9.27 | -10.79% | +316.25% | +327.04 | 0 Comment | |
epc53 | 27.06 | 7/20/2009 |
![]() |
5Y | $6.00 | +37.83% | +342.89% | +305.05 | 0 Comment | |
MrTwo94 | 94.41 | 11/8/2012 |
![]() |
1Y | $1.37 | +503.65% | +198.70% | +304.95 | 0 Comment | |
MSFOBV1YH | 95.89 | 11/17/2009 |
![]() |
5Y | $11.18 | -26.03% | +276.25% | +302.28 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.